← Browse by Condition
Medical Condition
parkinson s disease
Total Trials
14
Recruiting Now
14
Trial Phases
Phase 3, Phase 1
ClinicalMetric tracks all active clinical trials for parkinson s disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — parkinson s disease Clinical Trials
How many clinical trials are currently recruiting for parkinson s disease?
ClinicalMetric currently tracks 14 actively recruiting clinical trials for parkinson s disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for parkinson s disease?
parkinson s disease research spans Phase 1 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a parkinson s disease clinical trial?
Eligibility criteria for parkinson s disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 3 1
Top Sponsors
2 trials
2 trials
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT00575081
Recruiting
Enrollment
5,000 pts
Location
United States
Sponsor
Vanderbilt University Medical ...
NCT07441915
Recruiting
Enrollment
50 pts
Location
Switzerland
Sponsor
University of Zurich
NCT06405334
Recruiting
Enrollment
100 pts
Location
United States
Sponsor
VA Office of Research and Deve...
NCT05576818 Phase 3
Recruiting
Enrollment
66 pts
Location
Egypt
Sponsor
Tanta University
NCT07284719
Recruiting
Enrollment
20 pts
Location
Denmark
Sponsor
Aarhus University Hospital
NCT05773885
Recruiting
Enrollment
40 pts
Location
Italy
Sponsor
IRCCS San Raffaele Roma
NCT06733077
Recruiting
Enrollment
80 pts
Location
United Kingdom
Sponsor
University of Exeter
NCT05516719
Recruiting
Enrollment
44 pts
Location
United Kingdom
Sponsor
University of Exeter
NCT06562569
Recruiting
Enrollment
40 pts
Location
United States
Sponsor
VA Office of Research and Deve...
NCT07227896
Recruiting
Enrollment
100 pts
Location
United States, Israe...
Sponsor
AbbVie
NCT05070013
Recruiting
Enrollment
20 pts
Location
United States
Sponsor
University of Nebraska
NCT02071134
Recruiting
Enrollment
1,500 pts
Location
United States, Argen...
Sponsor
Boston Scientific Corporation
NCT06683378 Phase 1
Recruiting
Enrollment
24 pts
Location
United States
Sponsor
Craig van Horne, MD, PhD
NCT06920134
Recruiting
Enrollment
5 pts
Location
Switzerland
Sponsor
Ecole Polytechnique Fédérale d...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology